BETA: Please send your feedback!
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2001
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Its products include Omadacycline and Sarecycline. The company was founded in February 2001 and is headquartered in Boston, MA.
website
Headquarters
Executives
Name | Title | Gender |
Michael F. Bigham, MBA, CPA | Chairman & Chief Executive Officer | Male |
Regina M. DeTore Paglia | Senior Vice President-Human Resources | Female |
William M. Haskel | Secretary, Senior VP & General Counsel | Male |
Douglas W. Pagn, MBA | Chief Financial & Accounting Officer | Male |
Evan Loh, MD | President, COO, Director & CMO | Male |
Randy Brenner | SVP-Regulatory, Quality & Technical Operations | Male |
Paul McGovern | Vice President-Clinical & Medical Affairs | null |
Mindful Investing Summary
Paratek Pharmaceuticals - Competitors and Related Companies
How Paratek Pharmaceuticals stacks up to its peers in the Biotechnology industry or with competing business segments.
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Vanda Pharmaceuticals
VNDA:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Akorn
AKRX:NAS
Pharmaceuticals: Major
—
MID cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Neurocrine Biosciences
NBIX:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Pernix Therapeutics
PTX:NAS
Pharmaceuticals: Other
—
MICRO cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Titan Pharmaceuticals
TTNP:NAS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- 3
- 4
- 5
- 5
- —
- 3
- 5
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership